Covid 19 Patients

COVID-19 home isolation: All you need to know about new guidelines for patients, caregivers

As per the latest guidelines, people who got infected with the coronavirus do not need to have a repeat test when the home isolation period gets over

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.

Bhandup mall fire: Mumbai Police book six for culpable homicide after blaze claims nine lives

Nine COVID-19 patients died of suffocation at the Sunrise Hospital, a designated COVID-19 facility in the mall building which was also affected by the fire

Diwali 2020: Andhra Pradesh, Karnataka, others allow sale of green crackers, here’s what you need to know

Green crackers come in two categories: one without barium salt and the other with lesser quantities of barium. Both would lead to a 30 percent to 35 percent emission reduction

Will monitor smoke levels during Diwali, says West Bengal pollution control board

After citizens voiced concerns about firecracker smoke endangering COVID-19 patients, WBPCB said it may consider banning firecrackers in vicinity of designated hospitals and quarantine centres

Delhi sees 43% rise in number of COVID-19 patients under home isolation in August

As of 1 September, of the total 15,870 active cases in the National Capital, more than half (8,119) were under home quarantine, data from the Delhi govt showed

Robot and trail of bubbles points researcher to how COVID-19 causes lung damage

The bubble mystery could be the 'missing link' in understanding why some patients weren’t getting enough oxygen.

Biological patterns underlying some of the most severe COVID-19 cases revealed by scientists

Treating severe COVID-19 might require an immunological reset, with drugs that could, in theory, restore the balance in the body.

DCGI approves psoriasis injection for 'restricted emergency use' to treat COVID-19 patients

Drugs Controller General of India approved monoclonal antibody injection Itolizumab for limited use to treat moderate to severe cases of COVID-19.

Cipla's remdevisir to cost Rs 4,000 per 100 mg vial in India; pricing among lowest globally: Report

Cipla India business chief executive officer Nikhil Chopra said that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing.